Here is a PDF of an FDA Registered Trial that we believe you will deem worthy of merit and consideration. This article is based on a:

  • 7 year study of 2,000 Cardiac patients

  • 1,000 patients received PRP

  • 1,000 had standard closure without PRP

View Trial PDF

  • Key Points to consider

Deep infections reduced               2% to 0.6%           70% reduction!

Superficial infections reduced      8% to 2%               75% reduction! 

Readmission rate reduced            4% to 0.8%            80% reduction!

Wound costs reduced                   $1.26M – $594k   >53% reduction!

If PRP can produce such a positive impact within cardiac surgeries, cannot the case also be made for implementing PRP as standard protocol for all surgical procedures?

“The routine use of platelet rich plasma should be considered for all patients undergoing sternotomy for cardiac surgical procedures”.

Years in Development

% FDA Registered

Years of Team Experience

% Satisfaction Guaranteed

Get In Touch

Phone –  785.320.5740
Toll Free – 844-868-7747
Email –
Address – 116 South 4th Street , Ste A
Manhattan, Kansas 66502

Contact Form

7 + 5 =